Renal Manifestations among Adult Sickle Cell Disease Patients: A Single Center Study in Khartoum, Sudan
- 1 Department of Medicine & Nephrology, University of Medical Sciences and Technology, Academy Charity Teaching Hospital, Khartoum, Sudan
- 2 Clinical Research Assistants, Department of Nephrology, Academy Charity Teaching Hospital, Khartoum, Sudan
- 3 Graduate Entry Medical School, University of Limerick, Ireland
Abstract
Sickle Cell Disease (SCD) in adults is one of the causes of renal abnormalities and Chronic Kidney Disease (CKD). In this retrospective study, we explore the renal manifestations among adult SCD patients. The subjects of the study are all adult patients diagnosed with sickle cell anaemia and admitted as to the Academy Charity Teaching Hospital, Khartoum/Sudan during the period (01/01/2015-31/12/2015). All adult SCD patients’ medical files have been reviewed focusing on personal and clinical data in addition to presence or absence of renal manifestations, a total of 51 adult patients with SCD have been admitted to Academy Charity Teaching Hospital, Khartoum/ Sudan. 11 patients have renal manifestations (21.5%). The mean age ± SD of SCD patients with renal manifestations was 20.2 ± 1.9 years, 63.6% were males, the mean Hb level was 6.9 ± 0.99 gm/dl, proteinuria was present among 81.8% of patients, followed by haematuria (36.4%) and End Stage Renal Failure (ESRF) (18.2%). Further prospective studies are needed to explore the renal abnormalities among adult SCD patients.
- Strouse, J. (2016) Sickle Cell Disease. Handbook of Clinical Neurology, 138, 311-324. https://doi.org/10.1016/B978-0-12-802973-2.00018-5
- Scheinman, J.I. (1994) Sickle Cell Nephropathy. In: Holliday, M., Barratt, T.M. and Avner, E.D., Eds., Pediatric Nephrology, Williams & Wilkins, Baltimore, 908-919.
- Banaga, A.S., Mohammed, E.B., Siddig, R.M., Salama, D.E., Elbashir, S.B., Khojali, M.O., Babiker, R.A., Elmusharaf, K. and Homeida, M.M. (2015) Causes of End Stage Renal Failure among Haemodialysis Patients in Khartoum State/Sudan. BMC Research Notes, 8, 502. https://doi.org/10.1186/s13104-015-1509-x
- Ataga, K.I., Derebail, V.K. andArcher, D.R. (2014) The Glomerulopathy of Sickle Cell Disease. American Journal of Hematology, 89, 907-914. https://doi.org/10.1002/ajh.23762
- Powars, D.R., Elliott-Mills, D.D., Chan, L., Niland, J., Hiti, A.L., Opas, L.M. and Johnson, C. (1991) Chronic Renal Failure in Sickle Cell Disease: Risk Factors, Clinical Course, and Mortality. Annals of Internal Medicine, 115, 614-620.
- Platt, O.S., Brambilla, D.J., Rosse, W.F., Milner, P.F., Castro, O., Steinberg, M.H. and Klug, P.P. (1994) Mortality in Sickle Cell Disease. Life Expectancy and Risk Factors for Early Death. The New England Journal of Medicine, 330, 1639-1644. https://doi.org/10.1056/NEJM199406093302303
- Alvarez, O., Montane, B., Lopez, G., Wilkinson, J. and Miller, T. (2006) Early Blood Transfusions Protect against Microalbuminuria in Children with Sickle Cell Disease. Pediatric Blood & Cancer, 47, 71-76. https://doi.org/10.1002/pbc.20645
- Iwalokun, B.A., Iwalokun, S.O., Hodonu, S.O., Aina, O.A. and Agomo, P.U. (2012) Evaluation of Microalbuminuria in Relation to Asymptomatic Bacteruria in Nigerian Patients with Sickle Cell Anemia. Saudi Journal of Kidney Diseases and Transplantation, 23, 1320-1330.
- Falk, R.J., Scheinman, J., Phillips, G., Orringer, E., Johnson, A. and Jennette, J.C. (1992) Prevalence and Pathologic Features of Sickle Cell Nephropathy and Response to Inhibition of Angiotensin-Converting Enzyme. The New England Journal of Medicine, 326, 910-915. https://doi.org/10.1056/NEJM199204023261402
- Bhathena, D.B. and Sondheimer, J.H. (1991) The Glomerulopathy of Homozygous Sickle Hemoglobin (SS) Disease: Morphology and Pathogenesis. Journal of the American Society of Nephrology, 1, 1241-1252.
- Maigne, G., Ferlicot, S., Galacteros, F., Belenfant, X., Ulinski, T., Niaudet, P., Ronco, P., Godeau, B., Durrbach, A., Sahali, S., et al. (2010) Glomerular Lesions in Patients with Sickle Cell Disease. Medicine, 89, 18-27. https://doi.org/10.1097/MD.0b013e3181ca59b6